Cartesian Therapeutics, Inc. — Director's Dealing 2024

Apr 10, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cartesian Therapeutics, Inc. (RNAC)
CIK: 0001453687
Period of Report: 2024-04-08

Reporting Person: Hoge Elizabeth (10% Owner)
Reporting Person: Seven One Eight Three Four Irrevocable Trust (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-04-08	Common Stock	C	2926764	—	Acquired	3036887	Indirect
2024-04-08	Common Stock	C	491853	—	Acquired	506377	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-04-08	Series A Non-Voting Convertible Preferred Stock	$	C	87802.950	Disposed		Common Stock (2926764)	Indirect
2024-04-08	Series A Non-Voting Convertible Preferred Stock	$	C	14755.609	Disposed		Common Stock (491853)	Indirect

Footnotes

F1: Following the approval by the stockholders of the issuer of the conversion of the Series A Non-Voting Convertible Preferred Stock of the issuer ("Series A Preferred Stock") into shares of common stock of the issuer ("Common Stock"), each share of Series A Preferred Stock automatically converted into 33-1/3 shares of Common Stock, subject to certain limitations, including that a holder of Series A Preferred Stock is prohibited from converting shares of Series Preferred Stock into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion.

F2: Shares are owned directly by Seven One Eight Three Four Irrevocable Trust (the "Trust"). The reporting person is a trustee and beneficiary of the Trust.